NDC 0713-0883

Evoxac

Cevimeline Hydrochloride

Evoxac is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Cosette Pharmaceuticals, Inc.. The primary component is Cevimeline Hydrochloride.

Product ID0713-0883_e1f9f25e-98d3-e9e5-e053-2995a90ae380
NDC0713-0883
Product TypeHuman Prescription Drug
Proprietary NameEvoxac
Generic NameCevimeline Hydrochloride
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2022-06-15
Marketing CategoryNDA /
Application NumberNDA020989
Labeler NameCosette Pharmaceuticals, Inc.
Substance NameCEVIMELINE HYDROCHLORIDE
Active Ingredient Strength30 mg/1
Pharm ClassesCholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0713-0883-01

100 CAPSULE in 1 BOTTLE, PLASTIC (0713-0883-01)
Marketing Start Date2022-06-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Evoxac" or generic name "Cevimeline Hydrochloride"

NDCBrand NameGeneric Name
0713-0883Evoxaccevimeline hydrochloride
63395-201Evoxaccevimeline hydrochloride
0054-0334Cevimeline HydrochlorideCevimeline Hydrochloride
16571-657Cevimeline HydrochlorideCevimeline Hydrochloride
40032-999cevimeline hydrochloridecevimeline hydrochloride
43386-999cevimeline hydrochloridecevimeline hydrochloride

Trademark Results [Evoxac]

Mark Image

Registration | Serial
Company
Trademark
Application Date
EVOXAC
EVOXAC
77641881 3736042 Live/Registered
DAIICHI SANKYO COMPANY, LIMITED
2008-12-31
EVOXAC
EVOXAC
75837264 2579509 Live/Registered
DAIICHI SANKYO COMPANY, LIMITED
1999-11-01
EVOXAC
EVOXAC
74350561 1980336 Dead/Cancelled
DAIICHI PHARMACEUTICAL CO., LTD.
1993-01-19

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.